|
Orthologous residues
|
|
PDGFRa (human): Y754‑p, PDGFRa (mouse): Y754‑p, PDGFRa (rat): Y753‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
[32P] bio-synthetic labeling, peptide sequencing, phosphoamino acid analysis, phosphopeptide mapping
|
|
Relevant cell lines - cell types - tissues:
AG1523 (fibroblast), PAE (endothelial)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
human, pig
|
|
Enzymes shown to modify site in vitro:
|
|
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
PDGF
|
|
|
|
increase
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
molecular association, regulation
|
|
Comments:
a 134kDa and a 70kDa protein
|